ORBIMED ADVISORS LLC — SEC insider filings

SEC reporting owner CIK 1055951. 207 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers the 50 most recent of 207 filings on record, filed 2025-02-19 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sionna Therapeutics, Inc. (SION)Director10—20 legs · 1,235,000 sh · $55,674,636—
Enliven Therapeutics, Inc. (ELVN)10% owner2—6 legs · 1,141,531 sh · $51,683,034—
Braveheart Bio, Inc. (BRVE)Director, 10% owner12 legs · 1,940,000 sh · $34,920,000—2
Xtant Medical Holdings, Inc. (XTNT)10% owner1—2 legs · 73,114,592 sh · $30,708,129—
Electra Therapeutics, Inc. (ETRA)Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
Disc Medicine, Inc. (IRON)Director3—27 legs · 370,551 sh · $20,108,066—
WINDWARD BIO GROUP AG (WWB)Director, 10% owner21 leg · 1,176,471 sh · $20,000,007—7
ADARx Pharmaceuticals, Inc. (ADRX)Director, 10% owner23 legs · 950,000 sh · $16,150,000—16
Q32 Bio Inc. (QTTB)Director, 10% owner12 legs · 1,875,000 sh · $15,000,000——
Aspen Neuroscience, Inc. (ASPE)Director, 10% owner21 leg · 1,000,000 sh · $15,000,000—10

+16 more issuers among the filings shown — every filing appears in the table below.

Insider filings — ORBIMED ADVISORS LLC

FiledFormIssuerReported transactionsSource
2026-11-184WINDWARD BIO GROUP AG (WWB)
jointly with OrbiMed Capital GP IX LLC
Purchase (P): 1,176,471 @ $17 · Conversion (C): 3,561,936 · Conversion (C): 1,611,008 · Option exercise (M): 216,668 @ $0.02 · Tax withholding (F): 232 @ $17 · Conversion (C): 3,561,936 (derivative) @ $0 · +2 moreEDGAR
2026-11-123WINDWARD BIO GROUP AG (WWB)
jointly with OrbiMed Capital GP IX LLC
Holdings only — no transactions reportedEDGAR
2026-11-104Electra Therapeutics, Inc. (ETRA)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Purchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-054Electra Therapeutics, Inc. (ETRA)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Purchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-11-044Aspen Neuroscience, Inc. (ASPE)
jointly with OrbiMed Capital GP VII LLC
Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 moreEDGAR
2026-10-293Aspen Neuroscience, Inc. (ASPE)
jointly with OrbiMed Capital GP VII LLC
Holdings only — no transactions reportedEDGAR
2026-09-304ADARx Pharmaceuticals, Inc. (ADRX)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd, OrbiMed Genesis GP LLC
Conversion (C): 10,690,530 · Conversion (C): 2,000,962 · Conversion (C): 769,601 · Conversion (C): 564,187 · Purchase (P): 300,249 @ $17 · Conversion (C): 7,127,019 · +13 moreEDGAR
2026-09-243ADARx Pharmaceuticals, Inc. (ADRX)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Israel GP II, L.P., OrbiMed Advisors Israel II Ltd
Holdings only — no transactions reportedEDGAR
2026-09-234Electra Therapeutics, Inc. (ETRA)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Conversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-08-124BlossomHill Therapeutics, Inc. (BLSM)
jointly with OrbiMed Capital GP VIII LLC
Conversion (C): 1,039,996 · Conversion (C): 1,049,283 · Purchase (P): 625,000 @ $16 · Conversion (C): 1,039,996 (derivative) @ $0 · Conversion (C): 1,049,283 (derivative) @ $0EDGAR
2026-08-114Braveheart Bio, Inc. (BRVE)
jointly with OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC
Conversion (C): 9,132,420 · Purchase (P): 1,666,667 @ $18 · Purchase (P): 273,333 @ $18 · Conversion (C): 40,000,000 (derivative) @ $0EDGAR
2026-07-294Scribe Therapeutics, Inc. (SCTX)
jointly with OrbiMed Capital GP VIII LLC
Conversion (C): 348,825 · Purchase (P): 1,000,000 @ $15 · Conversion (C): 2,065,672 (derivative) @ $0EDGAR
2026-07-094Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 85,918 @ $44.86EDGAR
2026-07-024Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 115,844 @ $45.50EDGAR
2026-06-244Enliven Therapeutics, Inc. (ELVN)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Sale (S): 24,846 @ $45.38 · Sale (S): 1,477 @ $45 · Sale (S): 787,024 @ $45.38 · Sale (S): 46,776 @ $45EDGAR
2026-06-174Enliven Therapeutics, Inc. (ELVN)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Sale (S): 9,086 @ $45.02 · Sale (S): 272,322 @ $45.02EDGAR
2026-06-154Shattuck Labs, Inc. (STTK)
jointly with OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC
Purchase (P): 1,041,667 (derivative) · Purchase (P): 208,333 (derivative)EDGAR
2026-06-094Shattuck Labs, Inc. (STTK)
jointly with OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC
Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative) · Conversion (C): 15,366,490 (derivative) · Conversion (C): 3,073,298 (derivative)EDGAR
2026-06-014Q32 Bio Inc. (QTTB)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Purchase (P): 1,250,000 @ $8 · Purchase (P): 625,000 @ $8EDGAR
2026-05-294Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 101 @ $44.49EDGAR
2026-05-114Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 48,546 @ $44.61 · Sale (S): 59,767 @ $44.58 · Sale (S): 184,639 @ $46.22EDGAR
2026-04-284Traws Pharma, Inc. (TRAW)
jointly with OrbiMed Capital GP VIII LLC
Purchase (P): 597,729 @ $1.67 · Purchase (P): 597,729 (derivative) · Purchase (P): 597,729 (derivative) · Purchase (P): 1,793,187 (derivative)EDGAR
2026-04-234Prelude Therapeutics Inc (PRLD)
jointly with OrbiMed Capital GP VI LLC, ORBIMED CAPITAL LLC, OrbiMed Genesis GP LLC
Purchase (P): 1,689,189 @ $4.44 · Purchase (P): 1,126,126 @ $4.44EDGAR
2026-04-214Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 52,397 @ $44.68 · Sale (S): 2,948 @ $44.52EDGAR
2026-04-164Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 47,814 @ $44.51 · Sale (S): 235,863 @ $44.64 · Sale (S): 226,906 @ $45.34EDGAR
2026-04-164ImageneBio, Inc. (IMA)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC
Purchase (P): 336,603 (derivative) · Purchase (P): 384,689 (derivative)EDGAR
2026-04-094Adicet Bio, Inc. (ACET)
jointly with OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52EDGAR
2026-02-044Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 1,890 @ $44.57 · Sale (S): 29,063 @ $44.58EDGAR
2025-12-294Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 33,356 @ $44.55EDGAR
2025-12-194Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 900 @ $44.50 · Sale (S): 100 @ $44.49 · Sale (S): 875 @ $44.49EDGAR
2025-12-184Keros Therapeutics, Inc. (KROS)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Disposition to issuer (D): 140,057 @ $17.75 · Disposition to issuer (D): 74,465 @ $17.75EDGAR
2025-11-264Sionna Therapeutics, Inc. (SION)
jointly with OrbiMed Capital GP VIII LLC
Sale (S): 94,583 @ $44.54 · Sale (S): 11,890 @ $44.60 · Sale (S): 1,600 @ $44.49EDGAR
2025-10-274PMV Pharmaceuticals, Inc. (PMVP)
jointly with OrbiMed Capital GP V LLC
Sale (S): 1,000,000 @ $1.52EDGAR
2025-10-104Adicet Bio, Inc. (ACET)
jointly with OrbiMed Capital GP V LLC, OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, OrbiMed Advisors Israel II Ltd, OrbiMed Israel GP II, L.P., OrbiMed Israel GP Ltd., OrbiMed Israel BioFund GP Limited Partnership
Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1EDGAR
2025-09-124PMV Pharmaceuticals, Inc. (PMVP)
jointly with OrbiMed Capital GP V LLC
Sale (S): 500,000 @ $1.80EDGAR
2025-09-024Shattuck Labs, Inc. (STTK)
jointly with OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC
Purchase (P): 5,255,106 @ $0.87 · Purchase (P): 1,051,021 @ $0.87 · Purchase (P): 10,111,384 (derivative) · Purchase (P): 2,022,277 (derivative) · Purchase (P): 15,366,490 (derivative) · Purchase (P): 3,073,298 (derivative)EDGAR
2025-08-124Turnstone Biologics Corp. (TSBX)
jointly with OrbiMed Capital GP VI LLC
Code (U): 3,099,265EDGAR
2025-07-304ImageneBio, Inc. (IKNA)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC
Grant/award (A): 83,611 @ $2.49EDGAR
2025-07-014Corvus Pharmaceuticals, Inc. (CRVS)
jointly with OrbiMed Capital GP V LLC
Option exercise/expiry (X): 1,397,684 @ $3.50 · Sale (S): 1,176,332 @ $4.16 · Option exercise/expiry (X): 1,397,684 (derivative) @ $0EDGAR
2025-06-264Passage BIO, Inc. (PASG)
jointly with OrbiMed Capital GP VII LLC
Sale (S): 231,600 @ $0.35 · Sale (S): 138,800 @ $0.33 · Sale (S): 213,257 @ $0.33EDGAR
2025-05-164NeuroPace Inc (NPCE)
jointly with OrbiMed Capital GP VI LLC
Sale (S): 134,136 @ $15.83 · Sale (S): 34,000 @ $15.94EDGAR
2025-04-244Passage BIO, Inc. (PASG)
jointly with OrbiMed Capital GP VII LLC
Sale (S): 78,049 @ $0.34 · Sale (S): 89,328 @ $0.34 · Sale (S): 68,195 @ $0.32EDGAR
2025-04-174Passage BIO, Inc. (PASG)
jointly with OrbiMed Capital GP VII LLC
Sale (S): 10,326 @ $0.38 · Sale (S): 61,638 @ $0.33 · Sale (S): 77,090 @ $0.33EDGAR
2025-04-144Xtant Medical Holdings, Inc. (XTNT)
jointly with Orbimed ROF II LLC
Sale (S): 56,004,974 @ $0.42 · Sale (S): 17,109,618 @ $0.42EDGAR
2025-04-114Compass Therapeutics, Inc. (CMPX)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC
Sale (S): 3,571,428 @ $1.59EDGAR
2025-04-044Edgewise Therapeutics, Inc. (EWTX)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC
Purchase (P): 372,578 @ $20.13 · Purchase (P): 124,193 @ $20.13EDGAR
2025-03-264Disc Medicine, Inc. (IRON)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC
Sale (S): 1,956 @ $54.11 · Sale (S): 3,026 @ $54.11 · Sale (S): 756 @ $54.11EDGAR
2025-03-214Disc Medicine, Inc. (IRON)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC
Sale (S): 13,517 @ $54.02 · Sale (S): 20,911 @ $54.02 · Sale (S): 5,228 @ $54.02 · Sale (S): 941 @ $54.01 · Sale (S): 1,457 @ $54.01 · Sale (S): 364 @ $54.01 · +3 moreEDGAR
2025-03-124Disc Medicine, Inc. (IRON)
jointly with OrbiMed Capital GP VI LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC
Sale (S): 68,766 @ $54.29 · Sale (S): 106,384 @ $54.29 · Sale (S): 26,596 @ $54.29 · Sale (S): 136 @ $55.01 · Sale (S): 211 @ $55.01 · Sale (S): 53 @ $55.01 · +9 moreEDGAR
2025-02-194MBX Biosciences, Inc. (MBX)
jointly with OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Purchase (P): 17,962 @ $9.90 · Purchase (P): 29,540 @ $9.85 · Purchase (P): 49,070 @ $10.84 · Purchase (P): 94,100 @ $10.84EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1055951 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs